Bromocriptine: A sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes

Medicine and Dentistry

• Bromocriptine 66%
• Cardiovascular System 33%
• Side Effect 33%
• Fatty Acid 33%
• Hemoglobin A1c 33%
• Maturity Onset Diabetes of the Young 33%
• Hypoglycemia 33%
• Monotherapy 33%
• Adrenergic Receptor Blocking Agent 33%
• Diabetes Mellitus 33%
• Edema 33%
• Insulin Release 33%
• Triacylglycerol 33%
• Dopamine 2 Receptor Stimulating Agent 33%
• Moderate Renal Impairment 33%
• Therapeutic Procedure 33%
• Absence 33%
• Patient 33%
• Inpatient 33%
• Adjustment 33%
• Plasma 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Bromocriptine Mesilate 100%
• Bromocriptine 66%
• Adrenergic Receptor Blocking Agent 33%
• Monotherapy 33%
• Non Insulin Dependent Diabetes Mellitus 33%
• Side Effect 33%
• Dopamine 2 Receptor Stimulating Agent 33%
• Triacylglycerol 33%
• Edema 33%
• Diabetes Mellitus 33%
• Fatty Acid 33%
• Hypoglycemia 33%
• Hemoglobin A1c 33%
• Moderate Renal Impairment 33%
• Absence 33%